Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cem Onal

Showing results (111-120 of 150) with videos related to

Pageof 15
Sort By:
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 25, 2020
Half-dose bevacizumab experience in relapsed ovarian cancer patients in Turkey due to formal regulations: similar effectiveness with lower rate of hypertensionFatih Kose, Songul Alemdaroglu, Huseyin Mertsoylu, et al.
The Prostate|April 27, 2021
Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatmentCem Onal, Fatih Kose, Gokhan Ozyigit, et al.
Journal of Bone Oncology|March 1, 2019
Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastasesYurday Ozdemir, Nese Torun, Ozan Cem Guler, et al.
The Prostate|August 7, 2024
Impact of definitive radiotherapy on metabolic response measured with <sup>68</sup>Ga-PSMA-PET/CT in patients with intermediate-risk prostate cancerCem Onal, Ozan C Guler, Nese Torun, et al.
Tumori|July 31, 2014
Practice patterns for oropharyngeal cancer in radiation oncology centers of TurkeyOmur Karakoyun-Celik, Musa Altun, Ali Olmezoglu, et al.
Therapeutic Advances in Medical Oncology|September 19, 2022
Real-world global data on targeting epidermal growth factor receptor mutations in stage III non-small-cell lung cancer: the results of the KINDLE studyAbdul Rahman Jazieh, Huseyin Cem Onal, Daniel Shao-Weng Tan, et al.
Acta Oncologica (Stockholm, Sweden)|May 17, 2021
Outcome and safety analysis of endometrial cancer patients treated with postoperative 3D-conformal radiotherapy or intensity modulated radiotherapyCem Onal, Sezin Yuce Sari, Guler Yavas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2025
Prediction of metastasis-free survival in patients with localized prostate adenocarcinoma using primary tumor and lymph node radiomics from pre-treatment PSMA-PET/CT scansApurva Singh, William Silva Mendes, Sang-Bo Oh, et al.
Journal of Neurosurgical Sciences|May 4, 2010
Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factorsF Birol Sarica, K Tufan, M Cekinmez, et al.
Cancers|February 27, 2026
Prediction of Metastasis-Free Survival in Patients with Localized Prostate Adenocarcinoma Using Delta Radiomics from Pre-Treatment PSMA-PET/CT Scans and DosiomicsApurva Singh, William Silva Mendes, Sang-Bo Oh, et al.
Pageof 15

Showing results (111-120 of 150) with videos related to

Sort By:
Pageof 15
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 25, 2020
Half-dose bevacizumab experience in relapsed ovarian cancer patients in Turkey due to formal regulations: similar effectiveness with lower rate of hypertensionFatih Kose, Songul Alemdaroglu, Huseyin Mertsoylu, et al.
The Prostate|April 27, 2021
Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatmentCem Onal, Fatih Kose, Gokhan Ozyigit, et al.
Journal of Bone Oncology|March 1, 2019
Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastasesYurday Ozdemir, Nese Torun, Ozan Cem Guler, et al.
The Prostate|August 7, 2024
Impact of definitive radiotherapy on metabolic response measured with <sup>68</sup>Ga-PSMA-PET/CT in patients with intermediate-risk prostate cancerCem Onal, Ozan C Guler, Nese Torun, et al.
Tumori|July 31, 2014
Practice patterns for oropharyngeal cancer in radiation oncology centers of TurkeyOmur Karakoyun-Celik, Musa Altun, Ali Olmezoglu, et al.
Therapeutic Advances in Medical Oncology|September 19, 2022
Real-world global data on targeting epidermal growth factor receptor mutations in stage III non-small-cell lung cancer: the results of the KINDLE studyAbdul Rahman Jazieh, Huseyin Cem Onal, Daniel Shao-Weng Tan, et al.
Acta Oncologica (Stockholm, Sweden)|May 17, 2021
Outcome and safety analysis of endometrial cancer patients treated with postoperative 3D-conformal radiotherapy or intensity modulated radiotherapyCem Onal, Sezin Yuce Sari, Guler Yavas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2025
Prediction of metastasis-free survival in patients with localized prostate adenocarcinoma using primary tumor and lymph node radiomics from pre-treatment PSMA-PET/CT scansApurva Singh, William Silva Mendes, Sang-Bo Oh, et al.
Journal of Neurosurgical Sciences|May 4, 2010
Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factorsF Birol Sarica, K Tufan, M Cekinmez, et al.
Cancers|February 27, 2026
Prediction of Metastasis-Free Survival in Patients with Localized Prostate Adenocarcinoma Using Delta Radiomics from Pre-Treatment PSMA-PET/CT Scans and DosiomicsApurva Singh, William Silva Mendes, Sang-Bo Oh, et al.
Pageof 15